HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francois Ghiringhelli Selected Research

Everolimus

12/2019Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francois Ghiringhelli Research Topics

Disease

41Neoplasms (Cancer)
04/2024 - 12/2006
24Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 09/2009
9Neoplasm Metastasis (Metastasis)
01/2022 - 07/2010
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2017
5Adenocarcinoma
04/2023 - 07/2014
4Disease Progression
08/2020 - 01/2017
3Anus Neoplasms (Anal Cancer)
04/2024 - 01/2022
3Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2013
3Prostatic Neoplasms (Prostate Cancer)
08/2020 - 02/2013
2Infections
04/2024 - 01/2022
2Ependymoma
08/2022 - 11/2012
2Carcinoma (Carcinomatosis)
01/2022 - 08/2021
2Melanoma (Melanoma, Malignant)
01/2022 - 08/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2020 - 05/2018
2Breast Neoplasms (Breast Cancer)
08/2020 - 12/2016
2Splenomegaly
05/2020 - 05/2018
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 10/2016
2Lung Neoplasms (Lung Cancer)
01/2019 - 11/2018
1Colitis
04/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2024
1Acute Kidney Injury (Acute Renal Failure)
04/2024
1Sarcoidosis (Schaumann Disease)
04/2024
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2023
1Renal Cell Carcinoma (Grawitz Tumor)
11/2023
1Heart Arrest (Cardiac Arrest)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Hand-Foot Syndrome
01/2023
1Intestinal Perforation
01/2023
1Asthenia
01/2023
1Rectal Neoplasms (Rectal Cancer)
08/2021
1Sarcoma (Soft Tissue Sarcoma)
05/2021
1COVID-19
11/2020
1Hypoalbuminemia
11/2020
1Lymphopenia (Lymphocytopenia)
11/2020
1Endometrial Neoplasms (Endometrial Cancer)
08/2020
1Ovarian Neoplasms (Ovarian Cancer)
08/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Mucositis
12/2019

Drug/Important Bio-Agent (IBA)

14Bevacizumab (Avastin)FDA Link
08/2022 - 09/2009
9Fluorouracil (Carac)FDA LinkGeneric
04/2024 - 09/2009
9Irinotecan (Camptosar)FDA LinkGeneric
08/2021 - 09/2009
8Biomarkers (Surrogate Marker)IBA
10/2023 - 10/2016
7Immune Checkpoint InhibitorsIBA
11/2023 - 01/2020
6Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2021 - 07/2010
5atezolizumabIBA
04/2024 - 10/2020
5Cisplatin (Platino)FDA LinkGeneric
04/2024 - 11/2012
5LigandsIBA
04/2024 - 12/2006
5folfirinoxIBA
01/2022 - 05/2018
4Leucovorin (Folinic Acid)FDA Link
08/2021 - 02/2015
3Programmed Cell Death 1 ReceptorIBA
04/2024 - 01/2020
3tremelimumabIBA
04/2023 - 01/2018
3durvalumabIBA
04/2023 - 01/2018
3Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2016
2HMPL-013IBA
04/2024 - 01/2023
2Docetaxel (Taxotere)FDA Link
04/2024 - 01/2022
2NivolumabIBA
04/2024 - 01/2017
2Monoclonal AntibodiesIBA
11/2023 - 10/2020
2RNA (Ribonucleic Acid)IBA
10/2023 - 04/2023
2GemcitabineFDA Link
04/2023 - 02/2015
2regorafenibIBA
01/2023 - 05/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2022 - 11/2012
2Cancer VaccinesIBA
01/2022 - 01/2022
2AntibodiesIBA
01/2022 - 08/2009
2AntigensIBA
11/2021 - 10/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021 - 09/2019
2Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2020 - 12/2016
2olaparibIBA
08/2020 - 12/2016
2EnzymesIBA
12/2019 - 12/2016
2raltitrexed (D 1694)IBA
09/2019 - 07/2010
2Lomustine (CCNU)FDA Link
01/2019 - 10/2016
2Angiogenesis InhibitorsIBA
05/2014 - 02/2013
1pembrolizumabIBA
04/2024
1avelumabIBA
04/2024
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2023
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2023
1Pyruvate KinaseIBA
10/2023
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2023
1trifluridine tipiracil drug combinationIBA
01/2023
1SuspensionsIBA
10/2022
1VaccinesIBA
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022
1B7-H1 AntigenIBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2021
1NucleotidesIBA
11/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Panitumumab (Vectibix)FDA Link
01/2021
1C-Reactive ProteinIBA
11/2020
1ProcalcitoninIBA
11/2020
1EverolimusFDA Link
12/2019

Therapy/Procedure

24Drug Therapy (Chemotherapy)
04/2024 - 07/2010
24Therapeutics
01/2023 - 08/2009
10Immunotherapy
11/2023 - 12/2006
4Radiotherapy
11/2023 - 10/2008
4Precision Medicine
08/2020 - 12/2016
2Chemoradiotherapy
01/2022 - 10/2016
2Neoadjuvant Therapy
08/2019 - 11/2018
2Induction Chemotherapy
01/2018 - 04/2015